BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 1718640)

  • 21. Decay-accelerating factor protects human trophoblast from complement-mediated attack.
    Cunningham DS; Tichenor JR
    Clin Immunol Immunopathol; 1995 Feb; 74(2):156-61. PubMed ID: 7530176
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cell-associated complement regulatory proteins and their relation to disease processes].
    Seya T
    Rinsho Byori; 1991 Dec; 39(12):1317-24. PubMed ID: 1723433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human astrocytes express membrane cofactor protein (CD46), a regulator of complement activation.
    Gordon DL; Sadlon TA; Wesselingh SL; Russell SM; Johnstone RW; Purcell DF
    J Neuroimmunol; 1992 Feb; 36(2-3):199-208. PubMed ID: 1370668
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure and flexibility of the multiple domain proteins that regulate complement activation.
    Kirkitadze MD; Barlow PN
    Immunol Rev; 2001 Apr; 180():146-61. PubMed ID: 11414356
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tissue expression of human decay accelerating factor, a regulator of complement activation expressed in mice: a potential approach to inhibition of hyperacute xenograft rejection.
    Cary N; Moody J; Yannoutsos N; Wallwork J; White D
    Transplant Proc; 1993 Feb; 25(1 Pt 1):400-1. PubMed ID: 7679815
    [No Abstract]   [Full Text] [Related]  

  • 26. The regulation of complement on cell surfaces.
    Devine DV
    Transfus Med Rev; 1991 Apr; 5(2):123-31. PubMed ID: 1726550
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-inflammatory and immunosuppressive effects of recombinant soluble complement receptors.
    Fearon DT
    Clin Exp Immunol; 1991 Oct; 86 Suppl 1(Suppl 1):43-6. PubMed ID: 1718643
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Location of WESb on decay-accelerating factor.
    Telen MJ; Rao N; Lublin DM
    Transfusion; 1995 Mar; 35(3):278. PubMed ID: 7533342
    [No Abstract]   [Full Text] [Related]  

  • 29. Membrane complement regulatory proteins in autoimmune and inflammatory tissue injury.
    Song WC
    Curr Dir Autoimmun; 2004; 7():181-99. PubMed ID: 14719381
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alternative complement pathway-mediated myeloid cell cytotoxicity: repertoire of membrane factors participating in regulation of C3 deposition and cytolysis.
    Matsumoto M; Sugita Y; Seya T
    Eur J Immunol; 1991 Aug; 21(8):1787-92. PubMed ID: 1714391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Complement regulation.
    Meri S; Jarva H
    Vox Sang; 1998; 74 Suppl 2():291-302. PubMed ID: 9704459
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complement regulatory activity of normal human intraocular fluid is mediated by MCP, DAF, and CD59.
    Sohn JH; Kaplan HJ; Suk HJ; Bora PS; Bora NS
    Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4195-202. PubMed ID: 11095615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced complement susceptibility of avidin-biotin-treated human erythrocytes is a consequence of neutralization of the complement regulators CD59 and decay accelerating factor.
    Zaltzman AB; Van den Berg CW; Muzykantov VR; Morgan BP
    Biochem J; 1995 May; 307 ( Pt 3)(Pt 3):651-6. PubMed ID: 7537958
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two modes of homologous C3 deposition on Ramos Burkitt's lymphoma cell substrains co-expressing DAF (CD55), CD59, and CR2 (CD21), and on cells lacking them.
    Seya T; Hara T; Okada M; Kojima A; Matsumoto M; Akedo H
    Int Immunol; 1992 Dec; 4(12):1361-71. PubMed ID: 1283697
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Complement regulatory membrane factors in experimental animal models].
    Okada N
    Nihon Rinsho Meneki Gakkai Kaishi; 1995 Dec; 18(6):631-3. PubMed ID: 8963768
    [No Abstract]   [Full Text] [Related]  

  • 36. Enhancement of the complement activating capacity of 17-1A mAb to overcome the effect of membrane-bound complement regulatory proteins on colorectal carcinoma.
    Gelderman KA; Kuppen PJ; Bruin W; Fleuren GJ; Gorter A
    Eur J Immunol; 2002 Jan; 32(1):128-35. PubMed ID: 11754353
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transplantation of organs between species.
    White DJ
    Int Arch Allergy Immunol; 1992; 98(1):1-5. PubMed ID: 1378038
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Measles virus receptor CD46].
    Yanagi Y
    Uirusu; 1995 Dec; 45(2):159-64. PubMed ID: 8820534
    [No Abstract]   [Full Text] [Related]  

  • 39. Functional properties of membrane cofactor protein of complement.
    Seya T; Atkinson JP
    Biochem J; 1989 Dec; 264(2):581-8. PubMed ID: 2481448
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Kidney and complement regulatory factors].
    Matsuo S
    Nihon Rinsho Meneki Gakkai Kaishi; 1995 Dec; 18(6):643-6. PubMed ID: 8963771
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.